[go: up one dir, main page]

SE9803158D0 - A new composition - Google Patents

A new composition

Info

Publication number
SE9803158D0
SE9803158D0 SE9803158A SE9803158A SE9803158D0 SE 9803158 D0 SE9803158 D0 SE 9803158D0 SE 9803158 A SE9803158 A SE 9803158A SE 9803158 A SE9803158 A SE 9803158A SE 9803158 D0 SE9803158 D0 SE 9803158D0
Authority
SE
Sweden
Prior art keywords
composition
solvate
pharmaceutically acceptable
acceptable salt
free base
Prior art date
Application number
SE9803158A
Other languages
Swedish (sv)
Inventor
John Evenden
Seth-Olov Thorberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9803158A priority Critical patent/SE9803158D0/en
Publication of SE9803158D0 publication Critical patent/SE9803158D0/en
Priority to AU63782/99A priority patent/AU6378299A/en
Priority to JP2000569804A priority patent/JP2002524510A/en
Priority to CA002342233A priority patent/CA2342233A1/en
Priority to PCT/SE1999/001599 priority patent/WO2000015220A1/en
Priority to EP99951321A priority patent/EP1113793A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This invention relates to a composition comprising (R)-5-carbamoyl-8- fluoro-3-N,N- dicyclobutylamino-3, 4-dihydro-2H- 1-benzopyran in the form of the free base, or a pharmaceutically acceptable salt and/or solvate thereof, and (+)-1-[3-(dimethylamino)propyl]- 1-(p-fluorophenyl)- 5-phthlalancarbonitrile in the form of the free base, or a pharmaceutically acceptable salt and/or solvate thereof, the preparation thereof, pharmaceutical formulations containing said composition, use of and a method of treatment of affective disorders such as mood disorders and anxiety disorders with said composition as well as a kit containing said composition.
SE9803158A 1998-09-16 1998-09-16 A new composition SE9803158D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE9803158A SE9803158D0 (en) 1998-09-16 1998-09-16 A new composition
AU63782/99A AU6378299A (en) 1998-09-16 1999-09-13 A new composition
JP2000569804A JP2002524510A (en) 1998-09-16 1999-09-13 New composition
CA002342233A CA2342233A1 (en) 1998-09-16 1999-09-13 A new composition
PCT/SE1999/001599 WO2000015220A1 (en) 1998-09-16 1999-09-13 A new composition
EP99951321A EP1113793A1 (en) 1998-09-16 1999-09-13 A new composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803158A SE9803158D0 (en) 1998-09-16 1998-09-16 A new composition

Publications (1)

Publication Number Publication Date
SE9803158D0 true SE9803158D0 (en) 1998-09-16

Family

ID=20412629

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803158A SE9803158D0 (en) 1998-09-16 1998-09-16 A new composition

Country Status (6)

Country Link
EP (1) EP1113793A1 (en)
JP (1) JP2002524510A (en)
AU (1) AU6378299A (en)
CA (1) CA2342233A1 (en)
SE (1) SE9803158D0 (en)
WO (1) WO2000015220A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR021155A1 (en) 1999-07-08 2002-06-12 Lundbeck & Co As H TREATMENT OF NEUROTIC DISORDERS
EA008372B1 (en) * 2000-07-07 2007-04-27 Х.Лундбекк А/С Use of escitalopram for treating disorders associated with social anxiety disorder
EA008373B1 (en) * 2000-07-07 2007-04-27 Х. Лундбекк А/С Use of escitalopram useful in the treatment of disorders associated with post traumatic stress disorder
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (en) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
EP1113793A1 (en) 2001-07-11
WO2000015220A1 (en) 2000-03-23
CA2342233A1 (en) 2000-03-23
AU6378299A (en) 2000-04-03
JP2002524510A (en) 2002-08-06

Similar Documents

Publication Publication Date Title
NO20093464L (en) New drug mixtures based on anti-cholinergically effective compounds and beta-mimetics
SE9501567D0 (en) A new combination
EE200300033A (en) Cyclopentanoindoles, their use in the preparation of a medicament, and the pharmaceutical composition containing them
IS6520A (en) New compounds
DK1244435T5 (en) Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
MY106315A (en) Pharmaceutical agents
IS6658A (en) New compounds
RS49756B (en) Use of xenon for preparing a pharmaceutical preparation for treating neurointoxications
ATE269846T1 (en) N-SUBSTITUTED AMINOTETRALINES AS NEUROPEPTIDE Y Y5 RECEPTOR LIGANDS AND THEIR USE IN THE TREATMENT OF OBESITY AND OTHER DISEASES
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
SE9800836D0 (en) New Compounds
DK1346041T3 (en) Therapeutic agents and methods for their use in the treatment of an amyloidogenic disease
SE0201544D0 (en) Novel compounds and thier use
SE0102036D0 (en) Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
MXPA03000548A (en) New combination of serotonin agonist (5ht2) and antagonist (5ht6)as pharmaceutical formulation.
ATE451123T1 (en) VAGINAL ADMINISTERED COMPOSITION FOR THE TREATMENT OF UTERINE DYSRHYTHMIA
SE0102055D0 (en) New Compounds
SE0104331D0 (en) Novel compounds
ATE369348T1 (en) CYCLIZED BENZAMIDE NEUROKININ ANTAGONISTS FOR USE IN THERAPY
DE60001687D1 (en) Suspensions containing trovafloxacin for oral use
TR200000737T2 (en) Substituted chroma derivatives.
EP1254668A3 (en) Combination of a serotonin reuptake inhibitor and a GABA-A alpha 2/3 agonist for use in anxiety and depression
SE9804126D0 (en) New pharmaceutical composition
SE9803158D0 (en) A new composition
SE9803157D0 (en) A new composition